Physiological significance of pericoronary inflammation in epicardial functional stenosis and global coronary flow reserve.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 09 2021
Historique:
received: 02 05 2021
accepted: 26 08 2021
entrez: 25 9 2021
pubmed: 26 9 2021
medline: 7 1 2022
Statut: epublish

Résumé

Both fractional flow reserve (FFR) and global coronary flow reserve (g-CFR) provide prognostic information in patients with stable coronary artery disease (CAD). Inflammation plays a vital role in impaired endothelial dysfunction and atherosclerotic progression, potentially predicting cardiovascular mortality. This study aimed to evaluate the physiological significance of pericoronary adipose tissue inflammation assessed by CT attenuation (PCATA) in epicardial functional stenosis severity and g-CFR in patients with CAD. A total of 131 CAD patients with a single de novo epicardial coronary stenosis who underwent coronary CT-angiography (CCTA), phase-contrast cine-magnetic resonance imaging (PC-CMR) and FFR measurement were studied. PCATA was assessed using the mean CT attenuation value. G-CFR was obtained by quantifying absolute coronary sinus flow (ml/min/g) by PC-CMR at rest and during maximum hyperemia. Median FFR, g-CFR, and PCATA values were 0.75, 2.59, and - 71.3, respectively. Serum creatinine, NT-proBNP, left ventricular end-diastolic volume, and PCATA were independently associated with g-CFR. PCATA showed a significant incremental predictive efficacy for impaired g-CFR (< 2.0) when added to the clinical risk model. PCATA was significantly associated with g-CFR, independent of FFR. Our results suggest the pathophysiological mechanisms linking perivascular inflammation with g-CFR in CAD patients.

Identifiants

pubmed: 34561466
doi: 10.1038/s41598-021-97849-5
pii: 10.1038/s41598-021-97849-5
pmc: PMC8463533
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19026

Informations de copyright

© 2021. The Author(s).

Références

Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):1009-17
pubmed: 26758412
J Am Coll Cardiol. 2011 Aug 9;58(7):740-8
pubmed: 21816311
Circulation. 2014 Jun 17;129(24):2518-27
pubmed: 24787469
Am Heart J. 1999 Nov;138(5 Pt 2):S419-20
pubmed: 10539839
J Magn Reson Imaging. 2001 Mar;13(3):361-6
pubmed: 11241807
J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54
pubmed: 25323250
Circulation. 2006 Oct 17;114(16):1761-91
pubmed: 17015792
J Intern Med. 2015 Nov;278(5):483-93
pubmed: 26260307
Circulation. 2000 Jun 13;101(23):2696-702
pubmed: 10851206
J Am Coll Cardiol. 2017 Aug 15;70(7):869-879
pubmed: 28797357
JACC Cardiovasc Imaging. 2021 Aug;14(8):1598-1610
pubmed: 33958312
JACC Cardiovasc Imaging. 2020 Mar;13(3):746-756
pubmed: 31422133
J Am Coll Cardiol. 2011 Mar 15;57(11):1271-9
pubmed: 21392641
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
JACC Cardiovasc Imaging. 2015 Jan;8(1):1-10
pubmed: 25592691
J Am Coll Cardiol. 2013 Oct 29;62(18):1639-1653
pubmed: 23954338
JACC Cardiovasc Imaging. 2013 Jun;6(6):668-71
pubmed: 23764095
Circ J. 2019 May 24;83(6):1220-1228
pubmed: 30996156
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2058-2068
pubmed: 30336810
Circulation. 2015 Jan 6;131(1):19-27
pubmed: 25400060
J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):435-449
pubmed: 27780758
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
Lancet. 2013 Feb 23;381(9867):629-38
pubmed: 23439102
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Circulation. 2015 Mar 17;131(11):e376
pubmed: 25779548
Circulation. 2018 Aug 28;138(9):929-944
pubmed: 30354446
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701474
JACC Cardiovasc Imaging. 2019 Oct;12(10):2000-2010
pubmed: 30772226
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Nucl Med. 2009 Mar;50(3):331-4
pubmed: 19223412
JACC Cardiovasc Imaging. 2013 Jun;6(6):660-7
pubmed: 23643286

Auteurs

Yoshihisa Kanaji (Y)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Tomoyo Sugiyama (T)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Toru Misawa (T)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Tatsuhiro Nagamine (T)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Yumi Yasui (Y)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Kai Nogami (K)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Hiroki Ueno (H)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Hidenori Hirano (H)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Masahiro Hada (M)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Masao Yamaguchi (M)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Rikuta Hamaya (R)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Eisuke Usui (E)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Department of Cardiology, Tsuchiura Kyodo General Hospital, 4-4-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan. kaz@joy.email.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH